MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03210cam a2200325 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
9290611103 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9290611103 |
| 035 ## - |
|---|
| -- |
(Sirsi) 9290611103 |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
WB 925 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
940214s1993 1 0 eng |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Research guidelines for evaluating the safety and efficacy of herbal medicines. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Manila : |
| Name of publisher, distributor, etc. |
WHO Regional Office for the Western Pacific, |
| Date of publication, distribution, etc. |
1993. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
86 p. |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
WHO regional office publications. |
| Name of part/section of a work |
Western Pacific series ; |
| Volume/sequential designation |
no. 8. |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Sets out detailed guidelines for conducting scientific research on the safety and efficacy of herbal medicines. The guidelines, which reflect the consensus reached by 17 experts in pharmacology, biochemistry, and traditional medicine, respond to the need to assure the safety of widely-used herbal medicines while also facilitating the search for new pharmaceutical products. Specific research criteria are covered together with general principles of investigation, including ethical concerns. The book has three parts. The first discusses the special properties of herbal medicines that need to be considered when designing research protocols, with attention given to the distinctive legal, ethical, and regulatory requirements surrounding research on these substances. The second part provides detailed guidance on the objectives of research, the contents of a research protocol, and the methods of investigation for non-clinical studies and for Phase I to Phase IV clinical trials. The responsibilities of investigators, sponsors, and ethics review boards are also discussed in detail. The third part, which forms the core of the book, presents three sets of research guidelines: for quality specifications of plant materials and preparations, for pharmacodynamic and general pharmacological studies of herbal medicines, and for toxicity investigation of herbal medicines. Topics covered range from the information required to establish the identity and quality of plant materials or preparations, through the selection of appropriate test systems for pharmacodynamic studies, to detailed advice on the many different tests, examinations, observations, and experimental procedures required, in experimental animals and controls, to establish the safety of herbal medicines. The guidelines are intended to facilitate the work of research scientists and clinicians while also furnishing some reference points for the governmental, industrial, and non-profit organizations providing financial support. The guidelines should also prove useful to the regulatory authorities who control the sale of these products and the governmental and medical agencies who supervise their use in the health care systems of Western Pacific countries. |
| 535 ## - |
|---|
| -- |
DC.WPRO |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
eng. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
kor. |
| 550 ## - ISSUING BODY NOTE |
|---|
| Issuing body note |
WHODOC |
| 561 ## - OWNERSHIP AND CUSTODIAL HISTORY |
|---|
| History |
WHO monograph |
| 596 ## - |
|---|
| -- |
4 |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine, Herbal. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Evaluation studies. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Plants, Medicinal. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Research. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Traditional Medicine. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization. |
| Subordinate unit |
Regional Office for the Western Pacific. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://apps.who.int/iris/">https://apps.who.int/iris/</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
NLM Classification Scheme |
| Koha item type |
Books |
